文献速递预防保健、筛查与疫苗儿童保健慢病管理

中国儿童青少年传染病全国监测分析(2008-2017)

Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017.
PubMed 文献 · BMJ · 2020-04-02

该研究基于2008至2017年中国大陆31省国家监测数据,分析6至22岁学生中44种法定传染病的诊断与死亡情况。结果显示传染病死亡率由2008年0.21/10万降至2017年0.07/10万,但2017年发病率因流行性腮腺炎和季节性流感回升至242/10万,HIV/AIDS在男性中增加五倍。

要点

  • 传染病死亡率从2008年0.21/10万降至2017年0.07/10万。
  • 2017年发病率回升至242/10万,主要与流行性腮腺炎和季节性流感相关。
  • HIV/AIDS在2011至2017年间增加五倍,男性尤为明显。

核心结论

  • 中国儿童青少年传染病控制成效显著,死亡已罕见,但区域不平等、疫苗接种、HIV/AIDS上升及持续存在疾病仍带来挑战。

主要发现

  • 传染病死亡率从2008年0.21/10万降至2017年0.07/10万。
  • 发病率从2008年280/10万降至2015年162/10万,2017年回升至242/10万,主要与流行性腮腺炎和季节性流感相关。
  • 排除流行性腮腺炎和流感后,疫苗可预防疾病发病率从2008年96/10万降至2017年7/10万。
  • HIV/AIDS在2011至2017年间增加五倍,男性尤为明显;猩红热病例在2008至2017年间翻倍。
  • 西部地区儿童青少年传染病负担仍不成比例地高。

临床怎么用

  • 应关注儿童青少年HIV/AIDS上升趋势,尤其是男性,并加强疫苗接种以维持疫苗可预防疾病的低发病率。
  • 需针对性减少西部地区传染病负担的区域不平等,并对季节性流感等呼吸道传染病保持早期有效应对。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To outline which infectious diseases in the pre-covid-19 era persist in children and adolescents in China and to describe recent trends and variations by age, sex, season, and province. DESIGN: National surveillance studies, 2008-17. SETTING: 31 provinces in mainland China. PARTICIPANTS: 4 959 790 Chinese students aged 6 to 22 years with a diagnosis of any of 44 notifiable infectious diseases. The diseases were categorised into seven groups: quarantinable; vaccine preventable; gastrointestinal and enteroviral; vectorborne; zoonotic; bacterial; and sexually transmitted and bloodborne. MAIN OUTCOME MEASURES: Diagnosis of, and deaths from, 44 notifiable infectious diseases. RESULTS: From 2008 to 2017, 44 notifiable infectious diseases were diagnosed in 4 959 790 participants (3 045 905 males, 1 913 885 females) and there were 2532 deaths (1663 males, 869 females). The leading causes of death among infectious diseases shifted from rabies and tuberculosis to HIV/AIDS, particularly in males. Mortality from infectious diseases decreased steadily from 0.21 per 100 000 population in 2008 to 0.07 per 100 000 in 2017. Quarantinable conditions with high mortality have effectively disappeared. The incidence of notifiable infectious diseases in children and adolescents decreased from 280 per 100 000 in 2008 to 162 per 100 000 in 2015, but rose again to 242 per 100 000 in 2017, largely related to mumps and seasonal influenza. Excluding mumps and influenza, the incidence of vaccine preventable diseases fell from 96 per 100 000 in 2008 to 7 per 100 000 in 2017. The incidence of gastrointestinal and enterovirus diseases remained constant, but typhoid, paratyphoid, and dysentery continued to decline. Vectorborne diseases all declined, with a particularly noticeable reduction in malaria. Zoonotic infections remained at low incidence, but there were still unpredictable outbreaks, such as pandemic A/H1N1 2009 influenza. Tuberculosis remained the most common bacterial infection, although cases of scarlet fever doubled between 2008 and 2017. Sexually transmitted diseases and bloodborne infections increased significantly, particularly from 2011 to 2017, among which HIV/AIDS increased fivefold, particularly in males. Difference was noticeable between regions, with children and adolescents in western China continuing to carry a disproportionate burden from infectious diseases. CONCLUSIONS: China's success in infectious disease control in the pre-covid-19 era was notable, with deaths due to infectious diseases in children and adolescents aged 6-22 years becoming rare. Many challenges remain around reducing regional inequalities, scaling-up of vaccination, prevention of further escalation of HIV/AIDS, renewed efforts for persisting diseases, and undertaking early and effective response to highly transmissible seasonal and unpredictable diseases such as that caused by the novel SARS-CoV-2 virus.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Dong Y, Wang L, Burgner DP, et al. Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017. BMJ. 2020. PMID: 32241761. doi:10.1136/bmj.m1043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。